CareTalk: Healthcare. Unfiltered. What Eli Lilly's Insulin Price Cut Really Means
Eli Lilly is slashing insulin prices by 70%. Have we entered a new era of drug affordability or is this announcement just a lot of hot air?
TOPICS
(0:34) Is the Eli Lilly’s Insulin price cut a big deal?
(2:07) What does the price cut mean for Americans who need Insulin?
(5:41) Why is Eli Lilly reducing the prices now?
(6:28) How have Insulin prices affected diabetics in the past?
(8:08) Why is Insulin so expensive in the United States?
(9:17) Who are the major players in the Insulin market?
(11:22) What will this cut mean for other drug pricing, drug companies and consumer costs?
(12:56) Does Lilly Stand to lose money from this decision?
ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.
Dive deeper into this episode and read our article, "Insulin Affordability in the US: Are We at a Turning Point?"
GET IN TOUCH
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
FOLLOW CARETALK
Spotify
Apple Podcasts
Google Podcasts
Follow us on LinkedIn
⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.